The Sumatriptan 50 mg Rectal Suppository is a solid dosage form designed for insertion into the rectum. Upon administration, it dissolves or melts, facilitating the release of sumatriptan for local and systemic absorption. This formulation is specifically used to treat migraine headaches and cluster headaches. It provides an alternative route of administration for patients who may experience nausea and vomiting with oral medications during migraine attacks, ensuring more consistent absorption and relief from symptoms.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Sumatriptan 50 mg Rectal Suppository is a solid dosage form designed for insertion into the rectum, where it dissolves or melts to release the active medication, sumatriptan, for local or systemic absorption. This route of administration is particularly useful for patients who may have difficulties with oral administration, such as nausea and vomiting, which are common symptoms associated with migraine headaches. The rectal route provides an alternative that can bypass gastrointestinal issues and can lead to rapid absorption of the medication into the bloodstream.
Sumatriptan is a selective serotonin receptor agonist that works by constricting blood vessels in the brain, which is believed to alleviate migraine and cluster headaches. It is part of a class of medications known as triptans, which are specifically used to relieve headache pain and other symptoms of migraines, such as nausea, vomiting, and sensitivity to light and sound.
When using sumatriptan rectal suppositories, it is important for patients to understand the correct method of insertion and to follow the dosing instructions provided by their healthcare provider. The suppository should be inserted just before or at the onset of a migraine or cluster headache for optimal effectiveness. It is also crucial for prescribers to consider the patient's overall health, including any cardiovascular risk factors, as sumatriptan can have contraindications in certain populations.
Patients and prescribers should be aware of potential side effects, which can include sensations of tingling, heat, heaviness, pressure, or tightness in different parts of the body, as well as drowsiness, dizziness, and fatigue. More serious side effects, although rare, may include heart attack, arrhythmias, or stroke, particularly in those with underlying heart disease. Therefore, a thorough medical history and assessment are necessary before initiating treatment with sumatriptan.
For those interested in using Sumatriptan 50 mg Rectal Suppository for the treatment of migraine or cluster headaches, or for more detailed information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is available to answer any questions and provide guidance to ensure safe and appropriate use of this medication.
Sumatriptan is a medication commonly used to treat migraine headaches by narrowing blood vessels around the brain and reducing substances in the body that can trigger headache pain, nausea, sensitivity to light and sound, and other migraine symptoms. When formulated as a 50 mg rectal suppository, sumatriptan is used for its rapid onset of action and is particularly useful for patients who experience nausea and vomiting with their migraines, making oral administration challenging.
However, sumatriptan has several important drug interactions that both patients and prescribers should be aware of. Concurrent use with monoamine oxidase inhibitors (MAOIs) is contraindicated as it can lead to a significant increase in sumatriptan's systemic exposure, which may result in more severe side effects, including hypertensive reactions. A minimum of two weeks should elapse after discontinuing MAOI therapy before initiating sumatriptan treatment.
Sumatriptan should be used with caution in patients taking selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), or other serotonergic substances, as these can increase the risk of serotonin syndrome, a potentially life-threatening condition. Symptoms of serotonin syndrome may include mental status changes, autonomic instability, neuromuscular aberrations, and/or gastrointestinal symptoms. If symptoms arise, immediate medical attention is necessary.
Combining sumatriptan with other medications in the same class, such as other triptans or ergotamines, is not recommended within 24 hours due to the increased risk of coronary artery vasospasm, prolonged vasospastic reactions, and hypertension. Patients should be monitored closely for cardiovascular symptoms if there is a clinical need to co-administer these drugs.
Sumatriptan may also interact with medications that affect hepatic enzyme CYP450 3A4. Inhibitors of this enzyme may increase sumatriptan levels, leading to enhanced effects and potential toxicity, while inducers may decrease its efficacy. Adjustments in sumatriptan dosage or alternative treatments may be necessary when used with such agents.
Patients with risk factors for coronary artery disease (CAD) should undergo a cardiovascular evaluation prior to receiving sumatriptan. Sumatriptan may cause coronary artery vasospasm and should not be given to patients with a history of CAD or those who have signs or symptoms consistent with CAD.
It is essential for patients to inform their healthcare provider of all medications they are taking, including prescription drugs, over-the-counter medications, herbal supplements, and recreational drugs before starting treatment with sumatriptan rectal suppositories. If you have any questions or concerns regarding potential drug interactions with sumatriptan or its use in specific disease states, please reach out to us at Bayview Pharmacy for further assistance.
The Sumatriptan 50 mg Rectal Suppository is a solid dosage form designed to be inserted into the rectum, where it dissolves or melts to release the active medication, sumatriptan, for absorption. Sumatriptan is a selective serotonin receptor agonist that specifically targets serotonin (5-HT1) receptors in the brain. Upon administration, sumatriptan causes vasoconstriction of the dilated cerebral arteries, which is believed to be a contributing factor in the pathophysiology of migraine headaches. By constricting these blood vessels, sumatriptan can help alleviate the pain associated with migraine attacks.
The rectal route of administration offers several advantages for migraine sufferers. It provides an alternative for patients who may have difficulty swallowing oral medications due to nausea and vomiting, which are common symptoms during a migraine attack. Additionally, rectal absorption bypasses the gastrointestinal tract, potentially leading to more consistent absorption, especially in the presence of gastric stasis that often accompanies migraines. This can result in a more rapid onset of action compared to oral formulations, which is crucial for relieving migraine symptoms.
Sumatriptan rectal suppositories are also beneficial for patients who require medication to be administered during a migraine attack that has already begun. The rectal route can provide systemic absorption, delivering the medication directly into the bloodstream, where it can reach the target sites in the brain to exert its therapeutic effects. This mode of administration can be particularly useful for patients who experience severe migraines that do not respond well to oral medications or for those who have contraindications to other routes of administration.
Sumatriptan is contraindicated in patients with a history of coronary artery disease, uncontrolled hypertension, or those who have had a previous stroke or transient ischemic attacks. As with any medication, there may be potential side effects, and it is essential to use sumatriptan under the guidance of a healthcare professional.
For more detailed information on the Sumatriptan 50 mg Rectal Suppository, or if you have any questions regarding this formulation, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication for the treatment of migraine headaches.
A Sumatriptan 50 mg Rectal Suppository is a solid dosage form containing the medication Sumatriptan, which is used to treat migraine headaches. It is designed to be inserted into the rectum, where it dissolves or melts to release the medication for absorption into the bloodstream.
The suppository is formulated to melt or dissolve after insertion into the rectum, allowing the Sumatriptan to be absorbed into the lining of the rectum and enter the bloodstream. This can provide systemic relief from migraine symptoms.
Sumatriptan Rectal Suppositories are typically prescribed to individuals who experience migraine headaches and may have difficulty taking oral medications due to nausea or vomiting, or those who have not found relief with other forms of Sumatriptan.
Sumatriptan Rectal Suppositories should be stored at room temperature, away from moisture and heat. Keep them in their original packaging until you're ready to use one. Ensure they are kept out of reach of children and pets.
As with any medication, side effects can occur. Common side effects might include rectal discomfort, dizziness, tingling sensations, warmth, redness, or heaviness in various parts of the body. If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately.
Usage frequency should be directed by a healthcare professional, but it is generally advised that you should not use more than one suppository per migraine attack, and no more than two suppositories within 24 hours. It’s important to follow your prescription guidelines.
Wash your hands thoroughly before and after insertion. Unwrap the suppository, and while lying on your side with your lower leg straightened and your upper leg bent, gently insert the suppository into the rectum with your finger. Remain lying down for a few minutes to ensure the suppository stays in place and can dissolve properly.
You should discuss the use of Sumatriptan Rectal Suppositories with your healthcare provider if you are pregnant or planning to become pregnant. They will weigh the benefits and risks to determine if this treatment is safe for you during pregnancy.
If you miss a dose, use it as soon as you remember if a migraine is present. Do not use extra to make up for a missed suppository. In case of overdose, contact your healthcare provider or local poison control center right away.
The Sumatriptan 50 mg Rectal Suppository is specifically designed and FDA-approved for the treatment of migraine headaches. Use for other conditions has not been established and should only be considered when prescribed by a healthcare provider.
Yes, Sumatriptan can interact with certain medications including other migraine treatments (triptans), monoamine oxidase inhibitors (MAOIs), antidepressants like SSRIs or SNRIs, as well as particular medical conditions. Always inform your healthcare provider of all medications you are taking and your full medical history prior to using Sumatriptan Rectal Suppositories.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository